Oncolytics Biotech Price To Sales Ratio Over Time
| ONC Stock | CAD 1.32 0.06 4.35% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Oncolytics Biotech Performance and Oncolytics Biotech Correlation. Oncolytics |
Cross Equities Price To Sales Ratio Analysis
Compare Oncolytics Biotech and related stocks such as Theratechnologies, Aptose Biosciences, and Resverlogix Corp Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TH | 686 | 4.6688 | 8.3981 | 12.827 | 13.5614 | 21.6407 | 47.5412 | 42.4932 | 14.8753 | 10.7464 | 17.4198 | 10.3874 | 0.5103 | 0.59 | 0.56 |
| APS | 24.1162 | 11.3131 | 11.3131 | 11.3131 | 11.3131 | 11.3131 | 11.3131 | 11.3131 | 11.3131 | 11.3131 | 11.3131 | 11.3131 | 11.3131 | 13.01 | 12.36 |
| RVX | 1.6 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.1 K | 2 K |
Oncolytics Biotech and related stocks such as Theratechnologies, Aptose Biosciences, and Resverlogix Corp Price To Sales Ratio description
Price to Sales Ratio is figured by comparing Oncolytics Biotech stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Oncolytics Biotech sales, a figure that is much harder to manipulate than other Oncolytics Biotech multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| Oncolytics Biotech | ONC |
| Classification | IT |
| Business Address | 322 11th Avenue |
| Exchange | Toronto Exchange |
CAD 1.32
Check out Oncolytics Biotech Performance and Oncolytics Biotech Correlation. To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Oncolytics Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.